Table 1.
The Demographic and Clinical Indicators in Different Groups.
| Parameter | Total (n = 100) | Group | P | |
|---|---|---|---|---|
| Warfarin Group (n = 51) | Rivaroxaban Group (n = 49) | |||
| Gender | ||||
| Male | 63 (63.00) | 31 (60.80) | 32 (65.30) | 0.640 |
| Female | 37 (37.00) | 20 (39.20) | 17 (34.70) | |
| Age | 58.00 (50.00-65.00) | 60.00 (50.00-66.00) | 57.00 (50.00-63.00) | 0.207 |
| BMI | 24.93 ± 3.16 | 24.84 ± 3.26 | 25.03 ± 3.09 | 0.767 |
| BMI | ||||
| <18.5 | 0.00 (0.00) | 0.00 (0.00) | 0.00 (0.00) | 0.977 |
| [18.5 to 24) | 46.00 (46.00) | 24 (47.10) | 22 (44.90) | |
| [24 to 28) | 36 (36.00) | 18 (35.30) | 18 (36.70) | |
| ≥28 | 18 (18.00) | 9 (17.60) | 9 (18.40) | |
| Smoking | 38 (38.00) | 24 (47.1) | 14 (28.60) | 0.057 |
| Drinking | 50 (50.00) | 23 (45.10) | 27 (55.10) | 0.317 |
| Hypertension | 71 (71.00) | 40 (78.40) | 31 (63.30) | 0.095 |
| Diabetes Mellitus | 30 (30.00) | 11 (21.60) | 19 (38.80) | 0.061 |
| Heart Failure | 20 (20.00) | 12 (23.50) | 8 (16.30) | 0.368 |
| Stroke | 6 (6.00) | 3 (5.90) | 3 (6.10) | 1.00 |
| Creatinine (μmol/L) | 82.65 (78.60-89.25) | 85.00 (78.75-89.00) | 81.20 (78.40-89.40) | 0.418 |
| Ejection Fraction (%) | 61.52 (58.95-63.04) | 61.57 (58.57-62.99) | 61.47 (60.00-63.00) | 0.825 |
| Left Atrial Size (mm) | 36.00 (32.00-43.00) | 36.00 (32.00-43.00) | 33.00 (32.00-43.00) | 0.430 |
| Hemoglobin (g/L) | 140.70 ± 12.22 | 140.49 ± 14.15 | 140.92 ± 9.97 | 0.861 |
| History of Bleeding Disorders | 5 (5.00) | 3 (5.90) | 2 (4.10) | 1.00 |
| CHADS2-VASC Score | 3.00 (2.00-4.00) | 3.00 (2.00-4.00) | 3.00 (2.00-3.00) | 0.243 |
| HAS-BLED Score | 2.00 (2.00-3.00) | 3.00 (2.00-3.00) | 2.00 (2.00-3.00) | 0.087 |